Amarin Corporation (NASDAQ:AMRN) Attempts To rebound: Should You Buy?
Despite the overall turmoil and bloodbath in the market, there are some corners that have been largely unscathed from the selloff. One of the sectors that remain promising at this point is biotech, and investors […]